Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment

Journal of Cystic Fibrosis

Volumn 10, Issue 6, 2011, Pages 466-469

  Ridderberg, Winnie ^a   Bendstrup, Karen E M ^a   Olesen, Hanne V ^a   Jensen Fangel, Søren ^a   Nørskov Lauritsen, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Achromobacter xylosoxidans; Cross infection; Cystic fibrosis

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CROSS INFECTION; DENMARK; GENOTYPE; HUMAN; LUNG FIBROSIS; LUNG TRANSPLANTATION; PRESCHOOL CHILD; SCHOOL CHILD;

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; ADULT; CARRIER STATE; CHILD; CROSS INFECTION; CYSTIC FIBROSIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEALTH FACILITY ENVIRONMENT; HUMANS; INCIDENCE; YOUNG ADULT;

EID: 81455158927     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.07.004     Document Type: Article

References (19)

1. Ridderberg W., Olesen H.V., Nørskov-Lauritsen N. Increased incidence of Achromobacter xylosoxidans infections in a Danish CF centre is not caused by cross infections. J Cyst Fibros Jun 2010, 9(Supplement 1):S34.
2. Davies J.C., Rubin B.K. Emerging and unusual gram-negative infections in cystic fibrosis. Semin Respir Crit Care Med Jun 2007, 28(3):312-321.
3. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet May 30 2009, 373(9678):1891-1904.
4. Raso T., Bianco O., Grosso B., Zucca M., Savoia D. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS Sep 2008, 116(9):837-841.
5. Rolston K.V., Messer M. The in-vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 40 antimicrobial agents. J Antimicrob Chemother Dec 1990, 26(6):857-860.
6. Hansen C.R., Pressler T., Nielsen K.G., Jensen P.O., Bjarnsholt T., Hoiby N. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros Jan 2010, 9(1):51-58.
7. Hansen C.R., Pressler T., Hoiby N., Gormsen M. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J Cyst Fibros Dec 2006, 5(4):245-251.
8. Van Daele S., Verhelst R., Claeys G., Verschraegen G., Franckx H., Van S.L., et al. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J Clin Microbiol Jun 2005, 43(6):2998-3002.
9. Krzewinski J.W., Nguyen C.D., Foster J.M., Burns J.L. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol Oct 2001, 39(10):3597-3602.
10. Lambiase A., Catania M.R., Del P.M., Rossano F., Terlizzi V., Sepe A., et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis Aug 2011, 30(8):973-980.
11. Kanellopoulou M., Pournaras S., Iglezos H., Skarmoutsou N., Papafrangas E., Maniatis A.N. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis Apr 2004, 23(4):336-339.
12. Vu-Thien H., Moissenet D., Valcin M., Dulot C., Tournier G., Garbarg-Chenon A. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis Nov 1996, 15(11):876-879.
13. Turabelidze D., Kotetishvili M., Kreger A., Morris J.G., Sulakvelidze A. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol Nov 2000, 38(11):4242-4245.
14. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol Sep 1995, 33(9):2233-2239.
15. Jørgensen I.M., Johansen H.K., Frederiksen B., Pressler T., Hansen A., Vandamme P., et al. Epidemic spread of Pandorea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr Pulmonol Nov 2003, 36(5):439-446.
16. Nørskov-Lauritsen N., Johansen H.K., Fenger M.G., Nielsen X.C., Pressler T., Olesen H.V., et al. Unusual distribution of Burkholderia cepacia complex species in Danish cystic fibrosis clinics may stem from restricted transmission between patients. J Clin Microbiol Aug 2010, 48(8):2981-2983.
17. Walter S., Gudowius P., Bosshammer J., Romling U., Weissbrodt H., Schurmann W., et al. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax Apr 1997, 52(4):318-321.
18. Leung M.K., Rachakonda L., Weill D., Hwang P.H. Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis. Am J Rhinol Mar 2008, 22(2):192-196.
19. Roby B.B., McNamara J., Finkelstein M., Sidman J. Sinus surgery in cystic fibrosis patients: comparison of sinus and lower airway cultures. Int J Pediatr Otorhinolaryngol Sep 2008, 72(9):1365-1369.